eXpDNATM Plasmid Platform: Expediting Plasmid DNA Production and Supply
Georgi Makin
31 May 2023
SHARE NOW
ATW
Cell Therapy
Gene Therapy
GMP
This Presentation from Advanced Therapies Week 2023 focusses on a new offering from Charles River for expediting plasmid DNA production and supply, the eXpDNATM platform.
During this session, Ramin Baghirzade, Senior Director, Gene Therapy at Charles River Laboratories begins by briefly introducing Charles River’s CDMO Solutions, before presenting on the current demand or need for plasmid DNA within the advanced therapies industry.
Ramin then unveils the eXpDNATM plasmid platform, before summarizing the session.
This Presentation was presented at Advanced Therapies Week 2023, in partnership with Charles River.
More like this
Cell and Gene Therapies News Round-Up: October 11
Welcome to Phacilitate’s weekly news round-up, which will bring you the latest advanced therapies news and resources each Friday in the lead up to Advanced Therapies Week 2025 in Dallas. This round-up covers manufacturing, investment, therapeutic development, clinical trials, and any stories making the headlines that week.
11 October 2024